- Research from the CDC has found that the mRNA vaccines, currently made only by Pfizer-BioNTech and Moderna for COVID-19, reduce the risk of infection by 91 percent in people who are fully vaccinated.
- They also found that it reduces the risk by 81 percent in people who are partially vaccinated.
- The vaccines reduce the severity in illness in vaccinated people who still get COVID-19.
- The Johnson & Johnson vaccine isn’t an mRNA vaccine.
New research from the Centers for Disease Control and Prevention (CDC) has found that the messenger RNA (mRNA) vaccines used against the coronavirus reduce the risk of COVID-19 infection by 91 percent in people who are fully vaccinated. For people who are partially vaccinated, the reduced risk drops to 81 percent.
The study, which was released this month as a preprint on MedRxiv, also shows that the vaccines reduce the severity of illness in both fully and partially vaccinated people who develop COVID-19.
The vaccine clinical trials conducted in 2020 showed that the mRNA vaccines produced by Pfizer-BioNTech and Moderna were extremely effective at preventing COVID-19. Those findings are holding up in the real world as millions of people across the world get vaccinated.
“Now with the real life data we are seeing again and again in different studies that these vaccines are very effective,” Dr. Inci Yildirim, a Yale Medicine vaccinologist, pediatric infectious diseases specialist, and associate professor of pediatrics, told Healthline.
“Vaccinated individuals are protected from getting the infection and transmitting the infection to others.”
Source: healthline